Published in Vaccine on May 06, 2002
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol (2006) 4.68
HIV-1 neuroimmunity in the era of antiretroviral therapy. Neurobiol Dis (2010) 1.32
Rapid recruitment of virus-specific CD8 T cells restructures immunodominance during protective secondary responses. J Virol (2005) 1.06
Implications of CTL-mediated killing of HIV-infected cells during the non-productive stage of infection. PLoS One (2011) 1.01
Nef-mediated MHC class I down-regulation unmasks clonal differences in virus suppression by SIV-specific CD8(+) T cells independent of IFN-gamma and CD107a responses. Virology (2009) 0.94
The Mamu B 17-restricted SIV Nef IW9 to TW9 mutation abrogates correct epitope processing and presentation without loss of replicative fitness. Virology (2008) 0.86
Viral dynamics model with CTL immune response incorporating antiretroviral therapy. J Math Biol (2012) 0.79
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med (2012) 22.75
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
Global patterns of influenza a virus in wild birds. Science (2006) 13.80
Airborne transmission of influenza A/H5N1 virus between ferrets. Science (2012) 13.48
Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A (2004) 12.39
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol (2005) 10.77
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio (2012) 8.54
Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science (2009) 7.80
Aetiology: Koch's postulates fulfilled for SARS virus. Nature (2003) 7.51
The severe acute respiratory syndrome. N Engl J Med (2003) 7.48
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet (2003) 6.52
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog (2007) 6.04
A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci U S A (2004) 5.76
Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis (2002) 5.64
Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol (2007) 4.86
Analysis of the genomic sequence of a human metapneumovirus. Virology (2002) 4.64
Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J Exp Med (2008) 3.97
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio (2012) 3.96
Virology: SARS virus infection of cats and ferrets. Nature (2003) 3.86
Metapneumovirus and acute wheezing in children. Lancet (2002) 3.64
Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev (2009) 3.61
The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science (2012) 3.50
Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science (2013) 3.38
Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis (2008) 3.37
Antigenic and genetic variability of human metapneumoviruses. Emerg Infect Dis (2004) 2.96
Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J Infect Dis (2003) 2.91
Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg Infect Dis (2005) 2.90
Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol (2004) 2.88
Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis (2010) 2.81
Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol (2006) 2.77
Surveillance of influenza A virus in migratory waterfowl in northern Europe. Emerg Infect Dis (2007) 2.76
Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine (2013) 2.69
Effects of influenza A virus infection on migrating mallard ducks. Proc Biol Sci (2009) 2.69
Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis (2004) 2.68
The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis (2007) 2.58
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments. Virus Res (2004) 2.43
Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. Nat Med (2004) 2.31
Pause on avian flu transmission research. Science (2012) 2.24
In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol (2010) 2.23
Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS One (2008) 2.20
Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. J Infect Dis (2013) 2.19
Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J Virol (2010) 2.19
Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol (2010) 2.17
Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature (2013) 2.17
Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia. Proc Natl Acad Sci U S A (2007) 2.13
Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med (2009) 2.12
Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus. J Virol (2005) 2.11
Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog (2007) 2.09
Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis (2009) 2.07
Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A. Proc Natl Acad Sci U S A (2003) 2.03
Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J Virol (2009) 1.99
Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med (2013) 1.95
Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol (2006) 1.90
Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc Natl Acad Sci U S A (2004) 1.89
Rat-to-human transmission of Cowpox infection. Emerg Infect Dis (2002) 1.87
Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes. J Immunol (2004) 1.87
Human picobirnaviruses identified by molecular screening of diarrhea samples. J Clin Microbiol (2010) 1.86
Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests. J Clin Microbiol (2008) 1.85
Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med (2003) 1.81
Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am J Pathol (2010) 1.81
Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog (2011) 1.80
Metagenomic analysis of the viral flora of pine marten and European badger feces. J Virol (2011) 1.79
Hepatitis E virus: an underestimated opportunistic pathogen in recipients of allogeneic hematopoietic stem cell transplantation. Blood (2013) 1.77
Detection of immune-complex-dissociated nonstructural-1 antigen in patients with acute dengue virus infections. J Clin Microbiol (2003) 1.71
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. Lancet (2004) 1.70
Public health and biosecurity. Restricted data on influenza H5N1 virus transmission. Science (2012) 1.66
Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J Virol (2005) 1.64
Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect (2002) 1.64
Towards improved influenza A virus surveillance in migrating birds. Vaccine (2006) 1.63
Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. Curr Opin Biotechnol (2007) 1.60
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets. PLoS One (2010) 1.59
Isolation of MERS coronavirus from a dromedary camel, Qatar, 2014. Emerg Infect Dis (2014) 1.59
Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol (2010) 1.55
Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes. Eur J Immunol (2002) 1.53
Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection. Nature (2005) 1.51
Animal models for the preclinical evaluation of candidate influenza vaccines. Expert Rev Vaccines (2010) 1.51
Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses. J Med Virol (2005) 1.48
Human papillomavirus infection in men who have sex with men participating in a Dutch gay-cohort study. Sex Transm Dis (2003) 1.47
Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS One (2009) 1.44
Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J Gen Virol (2004) 1.44
Pathogenesis of Influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. Am J Pathol (2011) 1.44
Incidence and risk factors of probable dengue virus infection among Dutch travellers to Asia. Trop Med Int Health (2002) 1.44
Current and future applications of dried blood spots in viral disease management. Antiviral Res (2012) 1.41
The multibasic cleavage site in H5N1 virus is critical for systemic spread along the olfactory and hematogenous routes in ferrets. J Virol (2012) 1.40
The future of research and publication on altered H5N1 viruses. J Infect Dis (2012) 1.39
Novel hepatitis E virus in ferrets, the Netherlands. Emerg Infect Dis (2012) 1.38
Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus. J Virol (2013) 1.37
In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques. J Virol (2010) 1.35
Rapid sequencing of the non-coding regions of influenza A virus. J Virol Methods (2006) 1.35
Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. J Virol (2013) 1.34
Seasonal influenza vaccine provides priming for A/H1N1 immunization. Sci Transl Med (2009) 1.32
Comparative study of different methods to genotype hepatitis C virus type 6 variants. J Virol Methods (2003) 1.32
Evolutionary dynamics of human and avian metapneumoviruses. J Gen Virol (2008) 1.32
New viruses in idiopathic human diarrhea cases, the Netherlands. Emerg Infect Dis (2014) 1.32